Literature DB >> 23746484

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

Emily G Severance1, Kristin L Gressitt, Cassie R Stallings, Andrea E Origoni, Sunil Khushalani, F Markus Leweke, Faith B Dickerson, Robert H Yolken.   

Abstract

The origin of inflammation in psychiatric disorders is not well understood. The translocation of commensal microbiota across the gastrointestinal barrier can result in a persistent state of low-grade immune activation and/or inflammation. We measured serological surrogate markers of bacterial translocation (soluble CD14 (sCD14) and lipopolysaccharide binding protein (LBP)) in two psychiatric cohorts and compared these levels to C-reactive protein (CRP), body mass index (BMI), and food-related and autoimmune antibodies. The two cohorts were composed of the following: (1) n=141 schizophrenia, n=75 bipolar disorder, n=78 controls; (2) n=78 antipsychotic-naïve first-episode schizophrenia, n=38 medicated first-episode schizophrenia. sCD14 seropositivity conferred a 3.1-fold increased odds of association with schizophrenia (multivariate regressions, OR=3.09, p<0.0001) compared to controls. Case-control differences in sCD14 were not matched by LBP. Quantitative levels of LBP, but not sCD14, correlated with BMI in schizophrenia (R(2)=0.21, p<0.0001). sCD14 and LBP also exhibited some congruency in schizophrenia with both significantly correlated with CRP (R(2)=0.26-0.27, p<0.0001) and elevated in females compared to males (p<0.01). Antipsychotic treatment generally did not impact sCD14 or LBP levels except for significant correlations, especially sCD14, with gluten antibodies in antipsychotic-naïve schizophrenia (R(2)=0.27, p<0.0001). In bipolar disorder, sCD14 levels were significantly correlated with anti-tissue transglutaminase IgG (R(2)=0.37, p<0.001). In conclusion, these bacterial translocation markers produced discordant and complex patterns of activity, a finding that may reflect an imbalanced, activated innate immune state. Whereas both markers may upregulate following systemic exposure to Gram-negative bacteria, non-lipopolysaccharide-based monocyte activation, autoimmunity and metabolic dysfunction may also contribute to the observed marker profiles.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BMI; C-reactive protein; CRP; Diet; GI; Gut; LBP; LPS; Macrophage; Mental illness; Metabolic syndrome; Microbiome; Psychosis; body mass index; gastrointestinal; lipopolysaccharide; lipopolysaccharide binding protein; sCD14; soluble CD14; tTG; tissue transglutaminase

Mesh:

Substances:

Year:  2013        PMID: 23746484      PMCID: PMC3732507          DOI: 10.1016/j.schres.2013.05.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  67 in total

1.  Antibodies to infectious agents in individuals with recent onset schizophrenia.

Authors:  F Markus Leweke; Christoph W Gerth; Dagmar Koethe; Joachim Klosterkötter; Inna Ruslanova; Bogdana Krivogorsky; E Fuller Torrey; Robert H Yolken
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-02       Impact factor: 5.270

2.  Autoimmune diseases, bipolar disorder, and non-affective psychosis.

Authors:  William W Eaton; Marianne G Pedersen; Philip R Nielsen; Preben Bo Mortensen
Journal:  Bipolar Disord       Date:  2010-09       Impact factor: 6.744

3.  Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Sunil Khushalani; Flora Leister; Shuojia Yang; Bogdana Krivogorsky; Armin Alaedini; Robert Yolken
Journal:  Biol Psychiatry       Date:  2010-05-14       Impact factor: 13.382

4.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

5.  Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia.

Authors:  S G Fillman; N Cloonan; V S Catts; L C Miller; J Wong; T McCrossin; M Cairns; C S Weickert
Journal:  Mol Psychiatry       Date:  2012-08-07       Impact factor: 15.992

6.  Gluten-free diet reduces adiposity, inflammation and insulin resistance associated with the induction of PPAR-alpha and PPAR-gamma expression.

Authors:  Fabíola Lacerda Pires Soares; Rafael de Oliveira Matoso; Lílian Gonçalves Teixeira; Zélia Menezes; Solange Silveira Pereira; Andréa Catão Alves; Nathália Vieira Batista; Ana Maria Caetano de Faria; Denise Carmona Cara; Adaliene Versiani Matos Ferreira; Jacqueline Isaura Alvarez-Leite
Journal:  J Nutr Biochem       Date:  2012-12-17       Impact factor: 6.048

Review 7.  Initial responses to endotoxins and Gram-negative bacteria.

Authors:  Didier Heumann; Thierry Roger
Journal:  Clin Chim Acta       Date:  2002-09       Impact factor: 3.786

8.  C-reactive protein is elevated in schizophrenia.

Authors:  Faith Dickerson; Cassie Stallings; Andrea Origoni; Crystal Vaughan; Sunil Khushalani; Shuojia Yang; Robert Yolken
Journal:  Schizophr Res       Date:  2012-12-04       Impact factor: 4.939

9.  Novel immune response to gluten in individuals with schizophrenia.

Authors:  Diana Samaroo; Faith Dickerson; Donald D Kasarda; Peter H R Green; Chiara Briani; Robert H Yolken; Armin Alaedini
Journal:  Schizophr Res       Date:  2009-09-11       Impact factor: 4.939

10.  Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

Authors:  M G Clemente; S De Virgiliis; J S Kang; R Macatagney; M P Musu; M R Di Pierro; S Drago; M Congia; A Fasano
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  81 in total

Review 1.  Inflammation in Mental Disorders: Is the Microbiota the Missing Link?

Authors:  Sophie Ouabbou; Ying He; Keith Butler; Ming Tsuang
Journal:  Neurosci Bull       Date:  2020-06-27       Impact factor: 5.203

2.  Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).

Authors:  Natalya S Weber; Kristin L Gressitt; David N Cowan; David W Niebuhr; Robert H Yolken; Emily G Severance
Journal:  Schizophr Res       Date:  2018-01-06       Impact factor: 4.939

Review 3.  Autism spectrum disorders and intestinal microbiota.

Authors:  Maria De Angelis; Ruggiero Francavilla; Maria Piccolo; Andrea De Giacomo; Marco Gobbetti
Journal:  Gut Microbes       Date:  2015

Review 4.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

5.  Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Lisa T Eyler; Rob Knight; Dilip V Jeste
Journal:  J Psychiatr Res       Date:  2018-01-31       Impact factor: 4.791

Review 6.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

Review 7.  The Central Nervous System and the Gut Microbiome.

Authors:  Gil Sharon; Timothy R Sampson; Daniel H Geschwind; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

Review 8.  Deciphering microbiome and neuroactive immune gene interactions in schizophrenia.

Authors:  Emily G Severance; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2018-11-22       Impact factor: 5.996

9.  Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production.

Authors:  Natalya A Uranova; P D Bonartsev; L V Androsova; V I Rakhmanova; V G Kaleda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-17       Impact factor: 5.270

10.  Monocyte and microglial activation in patients with mood-stabilized bipolar disorder.

Authors:  Joel Jakobsson; Maria Bjerke; Sara Sahebi; Anniella Isgren; Carl Johan Ekman; Carl Sellgren; Bob Olsson; Henrik Zetterberg; Kaj Blennow; Erik Pålsson; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2015-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.